U.S. News & World Report – Quotes H. Gilbert Welch, professor of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice, about the fundamental questions patients should ask regarding overtreatment and overdiagnosis.

BuzzFeed – Quotes Steven Woloshin, professor of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice, about the drug Addyi, which treats low sex drive in women and recently gained FDA approval. “It’s politicizing what should be a scientific judgment,” says Woloshin. “I think there is a line that gets crossed when you turn the approval process into a political arena.”

U.S. News & World Report – Cites research conducted by the Dartmouth Institute for Health Policy and Clinical Practice, which found that 30 percent of Medicare spending goes to care that is unnecessary or harmful.

Valley News – John Saroyan, clinical associate professor of medicine and medical director with Bayada Hospice in Vermont and New Hampshire, has been granted hospice medical director certification by the Hospice Medical Director Certification Board.

Contemporary OB/GYN – Quotes Charles Wira, professor of physiology and neurobiology and lead author of a study which found that hormonal changes during a woman’s menstrual cycle open a “window of vulnerability:” a time period during which the female reproductive tract is more susceptible to sexually transmitted infections (STIs). Their study may one day lead to better prevention of STIs and better understanding of the pathogenesis of autoimmune diseases and cancer progression.

Scientific American – SciAm story quotes Steven Woloshin, professor of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice, about how pharmaceutical companies use disease awareness campaigns as drug selling tactics. “Drug company sponsorship doesn’t mean the information is bogus—but it does raise a red flag because companies do stand to benefit from increasing diagnoses, which leads to more treatment,” says Woloshin.

The Conversation – An opinion piece by Timothy Lahey, associate professor of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice, on a recent study published in the prestigious journal The Lancet on a new Ebola vaccine that was “100% effective.” Lahey notes that the vaccine is wonderful news, but that for three reasons, we cannot know if the vaccine really worked, or how well. “Those reasons are the lack of placebo comparison, the way the investigators diagnosed vaccine failure and the possibility of statistical flukes,” says Lahey.

News Medical – Cites a study co-authored by Brenda Sirovich, associate professor of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice, recently published in the journal JAMA Internal Medicine. The study examined 16 national collections of clinical performance measures and found that more than 90 percent of 521 outpatient measures targeted underuse of care and only 7 percent addressed overuse of care.

The Atlantic – Quotes Sohail Mirza, professor of orthopaedic surgery and of the Dartmouth Institute for Health Policy and Clinical Practice, in an article about how some medical device manufacturing companies pay their employees to make favorable edits to Wikipedia entries on surgeries and procedures that mention their products, and sometimes ask doctors with financial ties to their company to request edits to Wikipedia text

Nutrition Action – Article quotes John Baron, professor of medicine, epidemiology, and community and family medicine emeritus, about a study on fiber and its role in preventing colon cancer.